Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration.

[1]  J. Isner,et al.  Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. , 1995, Circulation.

[2]  W. Stetler-Stevenson,et al.  Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. , 1997, Circulation.

[3]  N. Maruyama,et al.  Expression and structure of senescence marker protein-30 (SMP30) and its biological significance , 1999, Mechanisms of Ageing and Development.

[4]  Hyun Chul Lee,et al.  Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.

[5]  J. Isner,et al.  Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia , 2000, Circulation.

[6]  David J. Mooney,et al.  Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.

[7]  M. Komeda,et al.  Initial Effects of the Left Ventricular Repair by Plication May Not Last Long in a Rat Ischemic Cardiomyopathy Model , 2001, Circulation.

[8]  YoshihikoSaito,et al.  Initial Effects of the Left Ventricular Repair by Plication May Not Last Long in a Rat Ischemic Cardiomyopathy Model , 2001 .

[9]  Ren-Ke Li,et al.  Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. , 2002, The Journal of thoracic and cardiovascular surgery.

[10]  M. Komeda,et al.  Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study , 2002, Circulation.

[11]  M. Komeda,et al.  Angiotensin-Converting Enzyme Inhibitor Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair in Rats , 2002, Circulation.

[12]  Ren-Ke Li,et al.  Improved Left Ventricular Aneurysm Repair With Bioengineered Vascular Smooth Muscle Grafts , 2003, Circulation.

[13]  松林 景二,et al.  Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts , 2003 .

[14]  Stefanie Dimmeler,et al.  Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. , 2004, Circulation.

[15]  M. Komeda,et al.  Atrial Natriuretic Peptide Helps Prevent Late Remodeling After Left Ventricular Aneurysm Repair , 2004, Circulation.

[16]  Stefanie Dimmeler,et al.  Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease , 2004, Circulation.

[17]  S. Fazel,et al.  Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. , 2005, American Journal of Physiology. Heart and Circulatory Physiology.

[18]  Dai Fukumura,et al.  Engineering vascularized tissue , 2005, Nature Biotechnology.

[19]  Narutoshi Hibino,et al.  Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. , 2005, The Journal of thoracic and cardiovascular surgery.

[20]  Fen Chen,et al.  Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. , 2006, Tissue engineering.

[21]  J. Toguchida,et al.  Expression of the p16INK4A Gene Is Associated Closely with Senescence of Human Mesenchymal Stem Cells and Is Potentially Silenced by DNA Methylation During In Vitro Expansion , 2007, Stem cells.

[22]  Stephen F Badylak,et al.  The extracellular matrix as a biologic scaffold material. , 2007, Biomaterials.

[23]  M. Radisic,et al.  Pulsatile perfusion bioreactor for cardiac tissue engineering , 2008, Biotechnology progress.

[24]  M. Komeda,et al.  Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery. , 2008, The Journal of thoracic and cardiovascular surgery.

[25]  Christopher M O'Connor,et al.  Coronary bypass surgery with or without surgical ventricular reconstruction. , 2009, The New England journal of medicine.

[26]  R. Guyton,et al.  Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction. , 2010, Journal of the American College of Cardiology.

[27]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[28]  Jun Wu,et al.  Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. , 2010, Biomaterials.

[29]  Milica Radisic,et al.  Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. , 2010, Biomaterials.

[30]  D. Burkhoff,et al.  Impact of surgical ventricular reconstruction on stroke volume in patients with ischemic cardiomyopathy. , 2010, The Journal of thoracic and cardiovascular surgery.

[31]  S. Wutzler,et al.  Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network--a future therapy for ischemically challenged tissue. , 2011, The Journal of surgical research.

[32]  Milica Radisic,et al.  Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. , 2011, Biomaterials.

[33]  Stephen F Badylak,et al.  RETRACTED: Engineered whole organs and complex tissues , 2012, The Lancet.